Phase
Condition
Digestive System Neoplasms
Pancreatitis
Treatment
N/AClinical Study ID
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
General
Capable of giving written informed consent
Age ≥18 years
Pancreatic Cancer Cohort
- Diagnosed with localised pancreatic cancer amenable to resection (distalpancreatectomy, total pancreatectomy or Whipple's procedure).
OR - Diagnosed with inoperable localised pancreatic cancer and referred for further management (malignant control subgroup).
Pancreatic Cysts Cohort
- Presence of cystic lesions where MDT have agreed further diagnostic interventionprocedures (including FNA/EUS) necessary.
OR - Patient the MDT have agreed have resectable lesions suspicious for pancreatic malignancy and going to surgery.
Benign Cohort
- Referral for endoscopic cystogastrostomy for complicated acute pancreatitischaracterised by peripancreatic fluid collections and pseudocysts in development ormatured (non-resolving and requiring further intervention).
OR
Referral for cholecystectomy for cholocystitis/chololethiasis. OR
Patient planned to have endoscopy investigation for dyspepsia (normal controlsubgroup).
Exclusion
Exclusion Criteria:
General
Inability to provide written informed consent
Other known malignant condition, either active or in complete remission ≤5 years
HIV, hepatitis C, or any other known communicable disease
Study Design
Connect with a study center
Castle Hill Hospital, Hull University Teaching Hospitals NHS Trust
Cottingham, Kingston Upon Hull HU16 5JQ
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.